09.12.2012 Views

q 2006 by Taylor & Francis Group, LLC - Developers

q 2006 by Taylor & Francis Group, LLC - Developers

q 2006 by Taylor & Francis Group, LLC - Developers

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

2<br />

CONTENTS<br />

Passive Targeting of Solid<br />

Tumors: Pathophysiological<br />

Principles and Physicochemical<br />

Aspects of Delivery Systems<br />

S. M. Moghimi<br />

2.1 Introduction ...........................................................................................................................11<br />

2.2 Barriers to Extravasation.......................................................................................................12<br />

2.3 Selected Delivery Systems....................................................................................................12<br />

2.3.1 Liposomes..................................................................................................................12<br />

2.3.2 Polymeric Nanoparticles ...........................................................................................14<br />

2.3.3 Nanotechnology-Derived Nanoparticles ...................................................................15<br />

2.3.4 Macromolecular and Related Delivery .....................................................................16<br />

2.4 Conclusions ...........................................................................................................................16<br />

References ......................................................................................................................................17<br />

2.1 INTRODUCTION<br />

A solid tumor comprises two major cellular components: the tumor parenchyma and the stroma; the<br />

latter incorporating the vasculature and other supporting cells. As the tumor grows, in order to meet<br />

the metabolic requirements of an expanding population of tumor cells, the pre-existing blood<br />

vessels become subject to intense angiogenic pressure. Several factors produced <strong>by</strong> tumor cells<br />

and infiltrating immune-competent effector cells in the tumor parenchyma are believed to signal the<br />

development of new capillaries from the pre-existing vessels <strong>by</strong> capillary sprouting and/or dysregulated<br />

intussusceptive microvascular growth. 1 Further, in many solid tumors, endothelial cells<br />

destined to create new vessels are recruited not only from near<strong>by</strong> vessels, but also to a significant<br />

extent from precursor cells within the bone marrow (so-called endothelial progenitor cells),<br />

a process referred to as “vasculogenesis.” 2<br />

Scanning electron microscopy of microvascular corrosion casts has allowed visualization of the<br />

geometry of blood vessel architecture in solid tumors. From these studies, it has become apparent<br />

that tumor blood vessels are highly irregular and show gross architectural changes that differ from<br />

those in normal organs and from newly formed blood vessels, such as those found in wound healing<br />

and in other angiogenic sites. 1,3 For instance, the thickness of a tumor blood vessel wall is poorly<br />

q <strong>2006</strong> <strong>by</strong> <strong>Taylor</strong> & <strong>Francis</strong> <strong>Group</strong>, <strong>LLC</strong><br />

11

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!